Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications

Abstract:
Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications.

Kodak Launches New Imaging Agent Product Line for Research Applications

NEW HAVEN, CT | Posted on February 13th, 2007

Once attached to a molecule and injected into an organism, the X-SIGHT imaging agents will travel to the target ( such as a tumor or plaque ) and illuminate the region of interest when excited by the appropriate wavelength of fluorescent light. X-SIGHT imaging agents are biocompatible and non-cytotoxic, making them safe and translatable for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They deliver not only superior brightness, but also enhanced photostability allowing more time for image capture.

This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, merging world-class dyes with a state-of-the-art nanoparticle construct. X-SIGHT imaging agents are uniquely designed to offer biocompatibility along with superior brightness, providing researchers an incredibly bright and robust platform for safely locating their target of interest in vivo.

Together with Kodak's In-Vivo Imaging Systems, the X-SIGHT Imaging Agent line further expands the breadth of leading-edge solutions offered from Kodak to the research community.

"The launch of X-SIGHT Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."

X-SIGHT imaging agents can be readily conjugated to a wide range of targeting molecules, including peptides and antibodies, and their proprietary design can accommodate higher payloads of such targets while allowing for longer circulation time. Furthermore, X-SIGHT imaging agents are available in several distinct fluorescent wavelengths, enabling multi-fluorescent in vivo imaging. While the X-SIGHT imaging agents have been optimized for Kodak's In-Vivo Imaging Systems, they are also compatible with other commercially available systems.

X-SIGHT imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak further plans to introduce additional imaging agents throughout the year.

####

About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group - part of Kodak’s Health Group - develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.

For more information, please click here

Contacts:
1-877-747-4357, express code 7.
Outside of the United States, call +1-203-786-5657.

Copyright © Eastman Kodak Company

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Products

Oxford Nanoimaging to provide desktop super-resolution microscopes May 10th, 2016

Abalonyx launches Reduced Graphene Oxide Product: Abalonyx has successfully scaled up production of thermally reduced graphene oxide (rGO) in its Tofte, Norway, production facility. This product is now offered to customers in Kg-quantities May 10th, 2016

New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016

New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016

Nanomedicine

Supercrystals with new architecture can enhance drug synthesis May 24th, 2016

Nanoscale Trojan horses treat inflammation May 24th, 2016

Programmable materials find strength in molecular repetition May 23rd, 2016

Tiny packages may pack powerful treatment for brain tumors: Nanocarrier provides efficient delivery of chemotherapeutic drug May 23rd, 2016

Announcements

Light can 'heal' defects in new solar cell materials: Defects in some new electronic materials can be removed by making ions move under illumination May 24th, 2016

Attosecond physics: A switch for light-wave electronics May 24th, 2016

Supercrystals with new architecture can enhance drug synthesis May 24th, 2016

Nanoscale Trojan horses treat inflammation May 24th, 2016

Human Interest/Art

Scientists propose non-animal tools for assessing the toxicity of nanomaterials: Particle and Fibre Toxicology publishes recommendations from expert group meeting April 26th, 2016

Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016

UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016

Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic